Pfizer applies for emergency use of coronavirus vaccine in U.S.

Pharmaceutical giant Pfizer Inc. on Friday became the first U.S. company to apply for emergency use authorization for its experimental coronavirus vaccine, marking a major step in the country’s fight against the pandemic.If authorized by U.S. regulators, the two-dose vaccine, developed with German partner BioNTech SE, could be used in high-risk populations in the United States by the end of December, Pfizer said on its website.The companies are also moving toward submitting applications in countries including Australia, Britain, Canada and Japan, the U.S. firm said.They expect to produce globa…

Read More

HEDGE accordingly